<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Adolor Corporation from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Adolor Corporation news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 13:07:51 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Adolor+Corporation" rel="self" type="application/rss+xml" />

	
<item><title>Form SC 13G/A ADOLOR CORP Filed by: BIOTECHNOLOGY VALUE FUND L P</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999920&amp;HITNO=0&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999920&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517728457%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999920&amp;HITNO=0&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999920&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517728457%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Adolor Corp. - Pharmaceuticals &amp; Healthcare - Deals And Alliances Profile - New Market Report Published</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3959310&amp;HITNO=1&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3959310&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2495730765%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3959310&amp;HITNO=1&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3959310&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2495730765%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>OfficialWire:</description></item>
<item><title>China Aoxing taps Hui Shao as CFO</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937941&amp;HITNO=2&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937941&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483754619%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937941&amp;HITNO=2&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937941&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483754619%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FierceBiotech:</description></item>
<item><title>BiomedReports: News and FDA Updates for Adolor (Nasdaq:ADLR), EpiCept (Nasdaq:EPCT), ERT (Nasdaq:ERES)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3914202&amp;HITNO=3&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3914202&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2470910927%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3914202&amp;HITNO=3&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3914202&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2470910927%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Adolor Corporation Announces Management Appointments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3908388&amp;HITNO=4&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3908388&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2467835073%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3908388&amp;HITNO=4&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3908388&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2467835073%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Adolor Corporation Announces Management Appointments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3907589&amp;HITNO=5&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3907589&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2467485701%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3907589&amp;HITNO=5&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3907589&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2467485701%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Adolor Corp. - Pharmaceuticals &amp; Healthcare - Deals And Alliances Profile - New Report Published</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3678127&amp;HITNO=6&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3678127&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2352857337%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3678127&amp;HITNO=6&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3678127&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2352857337%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>OfficialSpin:</description></item>
<item><title>Adolor begins clinical test of oral mu opioid receptor antagonist for OBD treatment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3634752&amp;HITNO=7&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3634752&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2333551703%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3634752&amp;HITNO=7&amp;MSIZE=8&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Adolor%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3634752&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2333551703%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PharmaBiz:</description></item>
</channel></rss>